| Patents for C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups (4,411) |
|---|
| 08/24/2006 | US20060189674 Deacetylase inhibitors |
| 08/23/2006 | EP1692097A1 Tricyclic hydroxamate and benzamide derivatives, compositions and methods |
| 08/23/2006 | CN1271066C Aromatic dicarboxylic acid derivatives |
| 08/17/2006 | WO2005107762A3 Certain chemical entities, compositions, and methods |
| 08/16/2006 | EP1689379A2 Methods of treating cancer with hdac inhibitors |
| 08/16/2006 | EP1689350A1 Use of osteopontin in dental formulations |
| 08/15/2006 | US7091378 Reacting under suitable conditions an ester with hydroxylamine in the presence of cyanide anion in an organic solvent |
| 08/10/2006 | WO2006084031A1 Imines as ion channel modulators |
| 08/10/2006 | CA2594505A1 Imines as ion channel modulators |
| 08/09/2006 | EP1688406A2 Polymeric resin compounds and their preparation |
| 08/09/2006 | EP1687301A1 Thiaepothilone for treating cancerous diseases |
| 07/27/2006 | WO2006020004A3 Histone deacetylase inhibitors |
| 07/27/2006 | US20060167316 Propargylether derivatives, a process for their preparation and their use for controlling phytopathogenic microorganisms |
| 07/27/2006 | US20060167103 Methods of treating cancer with HDAC inhibitors |
| 07/27/2006 | US20060166990 Novel aminobenzophenone compounds |
| 07/27/2006 | US20060166859 Compounds and compositions for delivering active agents |
| 07/26/2006 | EP1682495A1 Polymorphic form of n- (r)-2,3-dihydroxy-propoxy -3,4-d ifluoro-2-(2-fluoro-4-iodophenylamino)-benzamide |
| 07/26/2006 | CN1807394A Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| 07/19/2006 | CN1805930A Hydroxamic acids useful in the treatment of hyper-proliferative disorders |
| 07/18/2006 | US7078438 N-(4 substituted phenyl)-anthranilic acid hydroxamate esters |
| 07/13/2006 | US20060154988 intracellular inhibition of bacterial polypeptide deformylase in gramnegative bacteria, |
| 07/06/2006 | WO2006070878A1 Carboxylic acid derivative or salt thereof |
| 07/06/2006 | WO2006017215A3 Histone deacetylase inhibitors |
| 07/06/2006 | US20060148861 For treatment of psychotic disorders including schizophrenia, anxiety, depression and bipolar disorders; neurodegenerative diseases, epilepsy and pain including headaches and migraines |
| 07/05/2006 | EP1675594A2 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 07/05/2006 | EP0918514B9 Triaryl methane compounds for the treatment of cancer, actinic keratosis and kaposi's sarcoma |
| 07/04/2006 | US7071355 Enzyme inhibitors; anticancer agents; autoimmune diseases; antiprotozoa agents; viricides |
| 07/04/2006 | US7071214 Compounds and compositions for delivering active agents |
| 07/04/2006 | US7071212 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 07/04/2006 | US7070626 Oxidative coloring agents for keratin fibers |
| 06/28/2006 | EP1674484A2 Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid componds |
| 06/28/2006 | EP1674452A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor |
| 06/28/2006 | EP1674451A1 Method for producing n,n -dialkoxy-n,n -dialkyl oxamide |
| 06/28/2006 | EP1673075A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 06/28/2006 | CN1795175A Acetylene derivatives as inhibitors of histone deacetylase |
| 06/27/2006 | US7067551 Deacetylase inhibitors |
| 06/27/2006 | US7067119 Using polypeptides |
| 06/22/2006 | US20060135480 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex |
| 06/21/2006 | EP1309583B1 Process for preparing discodermolide and analogues thereof |
| 06/15/2006 | WO2006013209A3 Compounds for inhibiting copper-containing amine oxidases and uses thereof |
| 06/15/2006 | US20060128811 Hydroxamic acid- and N-formyl hydroxylamine hydrazide derivatives; veterinary medicine |
| 06/14/2006 | EP1667720A1 Combination of a histone deacetylase inhibitor with a death receptor ligand |
| 06/13/2006 | US7060856 Kinase inhibitors; dissolving in water, alcohol mixture; cooling; solvent extraction |
| 06/13/2006 | US7060683 for treatment of neurodegeneration, stroke, Alzheimer's, amyotrophy, motor neuron damage, acute central nervous system injury, muscular dystrophy, bone resorption, platelet aggregation, cataracts and inflammation |
| 06/08/2006 | US20060122268 Such as N1-(1-cyanocyclopropyl)-4-fluoro-N2-((1S)-2,2,2-trifluoro-1-(4' -(methylsulfonyl)-1,1'-biphenyl-4-yl) ethyl)-L-leucinamide; for treating osteoporosis and other bone loss disorders |
| 06/07/2006 | EP1663959A1 Novel amidine compounds for treating microbial infections |
| 06/07/2006 | CN1784380A Novel bioisosteres of actinonin |
| 06/06/2006 | US7057035 reacting aryl/heteroaryl triflate/halide with carbon monoxide and N-hydroxysuccinimide in solvent in presence of palladium catalyst and base |
| 06/06/2006 | CA2136903C Acetic acid derivatives |
| 06/01/2006 | WO2006017214A3 Inhibitors of histone deacetylase |
| 06/01/2006 | WO2006003068A3 Alpha-amino acid derivatives with antiinflammatory activity |
| 05/31/2006 | EP1660471A1 Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 05/31/2006 | EP1660437A1 Hydroxamic acid derivatives and the method for preparing thereof |
| 05/31/2006 | CN1257889C Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 05/30/2006 | US7053245 N-acylamino benzyl ether derivatives |
| 05/30/2006 | US7053234 Antibacterial agents |
| 05/24/2006 | EP1658263A1 Novel aminobenzophenone compounds |
| 05/24/2006 | CN1777577A Antibacterial agents |
| 05/23/2006 | US7049452 Preparation of fatty hydroxamate |
| 05/23/2006 | US7049343 Nitrogen compounds such as 3-(N'-(2,6-dinitro-4-trifluoro methylphenyl)-N-(3-methoxyphenylhydrazino)propionic acid, used as glycine transport antagonists for prophylaxis of psychological disorders |
| 05/17/2006 | EP1656348A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 05/16/2006 | US7045541 Compounds for the treatment of metabolic disorders |
| 05/16/2006 | US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout |
| 05/11/2006 | US20060100285 N-hydroxy-4-[2-(4-trifluoromethyl-phenyl)-acetylamino]-benzamide for example; treating infammatory, autoimmune diseases, tumors, and neurodegenerative diseases |
| 05/10/2006 | CN1769318A Polymeric resin compounds and their preparation |
| 05/09/2006 | US7041659 Compounds for the treatment of metabolic disorders |
| 05/04/2006 | US20060094708 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 05/03/2006 | EP1651163A2 Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same |
| 05/03/2006 | EP1208091B1 Benzophenones as inhibitors of reverse transcriptase |
| 05/03/2006 | CN1768031A Novel hydroxamates as therapeutic agents |
| 05/02/2006 | USRE39088 Amide compounds and use of the same |
| 04/26/2006 | CN1764450A Crystalline N-formyl hydroxylamine compounds |
| 04/25/2006 | US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease |
| 04/25/2006 | CA2194885C Substituted benzamidines, their preparation and their use as pharmaceutical compounds |
| 04/20/2006 | WO2006040625A1 Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation |
| 04/20/2006 | CA2583457A1 Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation |
| 04/19/2006 | EP1383736A4 Peptide deformylase inhibitors |
| 04/19/2006 | EP1383729A4 Peptide deformylase inhibitors |
| 04/13/2006 | WO2006038606A1 Biaryl derivative |
| 04/13/2006 | WO2006037761A1 New histone deacetylases inhibitors |
| 04/12/2006 | EP1644323A2 Histone deacetylase inhibitors and methods of use thereof |
| 04/12/2006 | EP1343771B1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors |
| 04/12/2006 | CN1759097A Chemical process for the preparation of intermediates to obtain N-formyl hydroxylamine compounds |
| 04/12/2006 | CN1250209C Inhibitor for 20-hydroxy-eicosatetraenoic acid enzyme |
| 04/11/2006 | CA2181570C Metalloproteinase inhibitors |
| 04/06/2006 | WO2005061501A3 Process for preparing hexahydropyrimido[1,2-a]azepine-2-carboxylates and related compounds |
| 04/05/2006 | CN1754899A Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and alpha, beta-unsaturated carboxylic acid and aldehyde compounds |
| 04/04/2006 | CA2258764C Inhibitors of oleamide hydrolase |
| 03/29/2006 | EP1638544A2 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions |
| 03/28/2006 | US7019003 Bactericides |
| 03/28/2006 | CA2395186C Procollagen c-proteinase inhibitors |
| 03/23/2006 | US20060063843 Compounds for the treatment of inflammatory disorders |
| 03/22/2006 | CN1246312C Antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| 03/22/2006 | CN1246304C Intermediate product for preparing benzamidoxime derivative |
| 03/22/2006 | CN1246300C Resorcinol derivatives |
| 03/16/2006 | WO2006027135A1 4-aminomethyl benzamidine derivatives and their use as factor viiia inhibitors |
| 03/16/2006 | US20060058553 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
| 03/16/2006 | US20060058294 Carboxamidine derivatives and their use in the treatment of vascular diseases |
| 03/16/2006 | US20060058282 Carbamic acid compounds comprising an ester or ketone linkage as hdac inhibitors |
| 03/16/2006 | CA2577608A1 4-aminomethyl benzamidine derivatives and their use as factor viia inhibitors |